Showing results (1-10 of 40) with videos related to
Sort By:
Pageof 4
Expert Opinion on Drug Discovery|March 19, 2013
The industrialisation of cellular screeningStephen Rees, Alan WiseDrug Discovery Today|February 13, 2002
Target validation of G-protein coupled receptorsAlan Wise, Katy Gearing, Stephen ReesAnnual Review of Pharmacology and Toxicology|January 28, 2004
The identification of ligands at orphan G-protein coupled receptorsAlan Wise, Steven C Jupe, Stephen ReesThe Journal of Pharmacology and Experimental Therapeutics|January 26, 2008
G protein coupling and ligand selectivity of the D2L and D3 dopamine receptorsJ Robert Lane, Ben Powney, Alan Wise, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 18, 2008
Antibodies that identify only the active conformation of G(i) family G protein alpha subunitsJ Robert Lane, David Henderson, Ben Powney, et al.Nutrition Reviews|June 5, 2008
Transcriptional switches in the control of macronutrient metabolismAlan WiseCurrent Opinion in Investigational Drugs (London, England : 2000)|April 16, 2004
Identification of a nicotinic acid receptor: is this the molecular target for the oldest lipid-lowering drug?Nicholas B Pike, Alan WiseMethods in Molecular Biology (Clifton, N.J.)|June 25, 2009
Use of primary human cells in high-throughput screensAngela Dunne, Mike Jowett, Stephen ReesExpert Opinion on Drug Discovery|November 12, 2013
High-throughput screening and structure-based approaches to hit discovery: is there a clear winner?Harren Jhoti, Stephen Rees, Roberto SolariReceptors & Channels|April 15, 2003
GPCR drug discovery through the exploitation of allosteric drug binding sitesStephen Rees, Dwight Morrow, Terry KenakinPageof 4